To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Airway Management Devices Market size was valued at USD 2 billion in 2022 and is poised to grow from USD 2.32 billion in 2023 to USD 3.62 billion by 2030, at a CAGR of 7.7% during the forecast period (2023-2030).

The existence of several major manufacturers competing for a sizable market share defines the competitive landscape of the airway management devices industry. To improve their market position, the businesses concentrate on developing innovative products, forming strategic alliances, and making acquisitions. They make significant investments in R&D to bring forth technologically cutting-edge and user-friendly airway management equipment. The businesses also participate in marketing campaigns and distribution alliances to broaden their reach internationally and boost their clientele. Additionally, new firms are entering the market, which increases competition. 'Medtronic (United States)', 'Smiths Medical (United States)', 'Teleflex Incorporated (United States)', 'Ambu A/S (Denmark)', 'Intersurgical Ltd. (United Kingdom)', 'Vyaire Medical Inc. (United States)', 'Medline Industries, Inc. (United States)', 'Flexicare Medical Limited (United Kingdom)', 'Mercury Medical (United States)', 'SunMed (United States)', 'Armstrong Medical Ltd. (United Kingdom)', 'Salter Labs (United States)', 'VBM Medizintechnik GmbH (Germany)', 'Medisize (Flex Ltd.) (United States)', 'Verathon Inc. (United States)', 'Intlock (Israel)', 'KARL STORZ SE & Co. KG (Germany)', 'UE Medical Devices Pvt. Ltd. (India)', 'Well Lead Medical Co., Ltd. (China)', 'Airways Corporation (India)'

The rising prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is a significant driver for the airway management devices market. These conditions necessitate the use of airway management devices for effective treatment and management.

In recent years, the market has experienced a number of significant market trends. The demand for sophisticated airway management systems with improved features and functions is one obvious trend. During airway procedures, these gadgets are intended to increase patient safety and deliver better results. The increasing use of video laryngoscopes, which provide better visualization and precision during intubation procedures, is another noteworthy trend. Additionally, due to their simplicity of use, speedy insertion, and low risk of problems, supraglottic airway devices are being used more frequently on the market. To reduce the chance of cross-contamination and guarantee infection control, there is also a move towards disposable airway management tools.

North America dominated the market in 2022 and is projected to remain the fastest growing region during the forecast period, due to the prevalence of asthma and chronic obstructive pulmonary disease, as well as the increase in the elderly population. The U.S. Census Bureau reports that as of 2017, more than 50 million Americans aged 65 and older were at the highest risk of developing chronic conditions. In North America, two important countries where such airway management devices have been widely adopted are the U.S. and Canada. The main causes of the rising need for airway management devices market forecast in North America are the rise in pollution rate and the increase in occurrences of respiratory problems, even in neonatal care. Increase in healthcare R&D spending, and the rising incidence of chronic diseases such as COPD, the U.S. market will experience considerable expansion during the forecast period due to favorable reimbursement policies.

Feedback From Our Clients

Global Airway Management Devices Market

Product ID: SQMIG35B2165

$5,300
BUY NOW